vs
科迪华（CTVA）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是Roper Technologies的1.9倍（$3.9B vs $2.1B），Roper Technologies净利率更高（15.8% vs -14.1%，领先29.9%），Roper Technologies同比增速更快（11.3% vs -1.7%），科迪华自由现金流更多（$4.2B vs $507.0M），过去两年Roper Technologies的营收复合增速更高（10.5% vs -6.7%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
CTVA vs ROP — 直观对比
营收规模更大
CTVA
是对方的1.9倍
$2.1B
营收增速更快
ROP
高出13.0%
-1.7%
净利率更高
ROP
高出29.9%
-14.1%
自由现金流更多
CTVA
多$3.6B
$507.0M
两年增速更快
ROP
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $2.1B |
| 净利润 | $-552.0M | $331.0M |
| 毛利率 | 42.4% | 69.4% |
| 营业利润率 | -13.6% | 27.2% |
| 净利率 | -14.1% | 15.8% |
| 营收同比 | -1.7% | 11.3% |
| 净利润同比 | -1246.3% | 842.6% |
| 每股收益（稀释后） | $-0.80 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVAROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $3.9B | $2.1B | ||
| Q3 25 | $2.6B | $2.0B | ||
| Q2 25 | $6.5B | $1.9B | ||
| Q1 25 | $4.4B | $1.9B | ||
| Q4 24 | $4.0B | $1.9B | ||
| Q3 24 | $2.3B | $1.8B | ||
| Q2 24 | $6.1B | $1.7B |
净利润CTVAROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $-552.0M | $428.4M | ||
| Q3 25 | $-320.0M | $398.5M | ||
| Q2 25 | $1.3B | $378.3M | ||
| Q1 25 | $652.0M | $331.1M | ||
| Q4 24 | $-41.0M | $462.3M | ||
| Q3 24 | $-524.0M | $367.9M | ||
| Q2 24 | $1.1B | $337.1M |
毛利率CTVAROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 42.4% | 69.5% | ||
| Q3 25 | 37.2% | 69.5% | ||
| Q2 25 | 54.6% | 69.2% | ||
| Q1 25 | 47.0% | 68.7% | ||
| Q4 24 | 37.3% | 68.3% | ||
| Q3 24 | 32.7% | 69.2% | ||
| Q2 24 | 52.3% | 69.5% |
营业利润率CTVAROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | -13.6% | 28.6% | ||
| Q3 25 | -14.1% | 28.4% | ||
| Q2 25 | 27.9% | 28.2% | ||
| Q1 25 | 17.7% | 27.9% | ||
| Q4 24 | 2.2% | 28.0% | ||
| Q3 24 | -27.2% | 28.1% | ||
| Q2 24 | 21.9% | 28.8% |
净利率CTVAROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | -14.1% | 20.8% | ||
| Q3 25 | -12.2% | 19.8% | ||
| Q2 25 | 20.4% | 19.5% | ||
| Q1 25 | 14.8% | 17.6% | ||
| Q4 24 | -1.0% | 24.6% | ||
| Q3 24 | -22.5% | 20.8% | ||
| Q2 24 | 17.2% | 19.6% |
每股收益（稀释后）CTVAROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-0.80 | $3.97 | ||
| Q3 25 | $-0.47 | $3.68 | ||
| Q2 25 | $1.92 | $3.49 | ||
| Q1 25 | $0.95 | $3.06 | ||
| Q4 24 | $-0.05 | $4.29 | ||
| Q3 24 | $-0.76 | $3.40 | ||
| Q2 24 | $1.51 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $382.9M |
| 总债务越低越好 | $1.7B | $9.7B |
| 股东权益账面价值 | $24.1B | $18.8B |
| 总资产 | $42.8B | $34.6B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资CTVAROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $4.5B | $297.4M | ||
| Q3 25 | $2.6B | $320.0M | ||
| Q2 25 | $2.1B | $242.4M | ||
| Q1 25 | $2.0B | $372.8M | ||
| Q4 24 | $3.2B | $188.2M | ||
| Q3 24 | $2.5B | $269.6M | ||
| Q2 24 | $2.0B | $251.5M |
总债务CTVAROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | $1.7B | $9.3B | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.0B | $7.6B | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.5B | — |
股东权益CTVAROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $24.1B | $19.9B | ||
| Q3 25 | $25.2B | $20.0B | ||
| Q2 25 | $25.9B | $19.6B | ||
| Q1 25 | $24.3B | $19.2B | ||
| Q4 24 | $23.8B | $18.9B | ||
| Q3 24 | $24.7B | $18.5B | ||
| Q2 24 | $25.2B | $18.1B |
总资产CTVAROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $42.8B | $34.6B | ||
| Q3 25 | $42.2B | $34.6B | ||
| Q2 25 | $41.8B | $33.2B | ||
| Q1 25 | $42.1B | $31.4B | ||
| Q4 24 | $40.8B | $31.3B | ||
| Q3 24 | $41.9B | $31.6B | ||
| Q2 24 | $41.5B | $29.8B |
负债/权益比CTVAROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | 0.07× | 0.47× | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | 0.40× | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | — |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $507.0M |
| 自由现金流率自由现金流/营收 | 106.2% | 24.2% |
| 资本支出强度资本支出/营收 | 5.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.8B | — |
8季度趋势，按日历期对齐
经营现金流CTVAROP
| Q1 26 | — | — | ||
| Q4 25 | $4.4B | $738.0M | ||
| Q3 25 | $193.0M | $869.5M | ||
| Q2 25 | $947.0M | $404.1M | ||
| Q1 25 | $-2.1B | $528.7M | ||
| Q4 24 | $4.2B | $722.2M | ||
| Q3 24 | $130.0M | $755.4M | ||
| Q2 24 | $451.0M | $384.1M |
自由现金流CTVAROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $4.2B | — | ||
| Q3 25 | $36.0M | — | ||
| Q2 25 | $829.0M | — | ||
| Q1 25 | $-2.2B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $-24.0M | — | ||
| Q2 24 | $337.0M | — |
自由现金流率CTVAROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 106.2% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 12.8% | — | ||
| Q1 25 | -49.9% | — | ||
| Q4 24 | 100.4% | — | ||
| Q3 24 | -1.0% | — | ||
| Q2 24 | 5.5% | — |
资本支出强度CTVAROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.0% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 1.9% | — |
现金转化率CTVAROP
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | 0.72× | 1.07× | ||
| Q1 25 | -3.23× | 1.60× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | 0.43× | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
ROP
暂无分部数据
